FIBRACILLIN is a semisynthetic antibacterial agent.

Pituxate is the antitussive and bronchospasmolytic agent.

Vanyldisulfamide is an anti-infective sulfonamide drug.

FLOXACRINE, a dihydroacridinedione derivative, is an antimalarial agent. It showed high potency against blood-induced infection of drug-sensitive and drug-resistant lines of Plasmodium berghei in animal models.

Timofibrate is a thiazolidine derivative patented by Italchemi S.p.A.-Istituto Chimico Farmaceutico as antiatherosclerosis, anticholesteremic, and liver protecting agent.

Diproxadol is the analgesic agent.

Morforex is phenylethylamine derivative that acts as central nervous system (CNS) and motor activity stimulant. Morforex produces amphetamine as an active metabolite.

Picoprazole is substituted benzimidazole. Picoprazole inhibited the gastric (H+ + K+)-ATPase in a concentration-and time-dependent manner, which may explain its inhibitory action on acid secretion in vitro and in vivo. This compound inhibits acid secretion at the level of the parietal cell by its ability to inhibit the gastric proton pump. Picoprazole affects pepsin secretion probably indirectly via its effect on the parietal cell. Studies on the (Na+ + K+)-ATPase indicated that this enzyme was unaffected by picoprazole.